Medicine guide

Aqumeldi

  • Prescription status not stated
  • Heart, blood pressure and circulation
Active substance
Enalapril maleate
Made by
Proveca Pharma Limited

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

  • Treatment of heart failure.

From the official label · 2026-09-30 · European Medicines Agency

How it works

From the US prescribing label for the same active substance (Enalapril Maleate). It describes the substance, not this exact product.

Enalapril, after hydrolysis to enalaprilat, inhibits angiotensin-converting enzyme (ACE) in human subjects and animals.

ACE is a peptidyl dipeptidase that catalyzes the conversion of angiotensin I to the vasoconstrictor substance, angiotensin II.

Peak level after20 min
Half-life11 h
Mostly cleared after≈ 2 daysfive half-lives — our arithmetic
PeakHalf gone2 days0
The shape is a standard model drawn from the two times above, not a measurement. How fast a medicine acts and wears off also depends on the dose, the form and the person.
With food

A high-fat meal reduced the C max of enalapril and enalaprilat by 46% and 36%, respectively.

Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2019-03-29

Same active substance, strength and form in other countries

Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.

Medicine passport: one printable page to show a pharmacist abroad

United StatesNo exact match for this strength and form

SpainNo exact match for this strength and form

CanadaNo exact match for this strength and form

NetherlandsNo exact match for this strength and form

SwitzerlandNo exact match for this strength and form

Details

Made byProveca Pharma Limited
Active substanceEnalapril maleate
Used inHeart, blood pressure and circulation
ClassificationC09AA02 · Heart, blood pressure and circulation
Authorised on2023-11-15
Last updated by the regulator2025-10-21
EMA product numberEMEA/H/C/005731

Source: European Medicines Agency — medicine data · 2026-09-30 · not reviewed by a clinician

Source: European Medicines Agency (EMA). Product information as published by EMA. Reuse terms: EMA legal notice (reproduction authorised).